Grifols, S.A. ( GRFS) - Stock Earnings
GRFS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 114.3 million USD | 2.3 billion USD |
| 2026Q1 | 85.0 million USD | 2.0 billion USD |
| 2026Q2 | 175.8 million USD | 2.1 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
GRFS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 46.8 million USD | 7.3 billion USD |
| 2024 | 163.4 million USD | 7.5 billion USD |
| 2025 | 453.3 million USD | 8.5 billion USD |
| 2026 Est. | — | — |
GRFS
Price: $7.80
Dividend Yield: 3.60%
Earnings Per Share: 0.76 USD
P/E Ratio: 10.36
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Spain
Volume: 924384
Ebitda: 362.6 millionMarket Capitalization: 6.6 billion
Years Paying Dividends: 2